Immorna
Hangzhou
About Immorna
Immorna specializes in the production of RNA-based therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $28.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Aug 2024)
- Website: immorna.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/immorna-92078 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.